Total Investment Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$294K Buy
256
+11
+4% +$11.2K 0.03% 62
2026
Q1
$225K Buy
245
+8
+3% +$8.11K 0.03% 74
2025
Q4
$255K Buy
+237
New +$227K 0.03% 66
2025
Q3
Sell
-261
Closed -$203K 514
2025
Q2
$203K Buy
261
+12
+5% +$9.32K 0.03% 74
2025
Q1
$206K Buy
+249
New +$207K 0.03% 72
2024
Q4
Sell
-261
Closed -$231K 77
2024
Q3
$231K Buy
261
+24
+10% +$21.6K 0.03% 62
2024
Q2
$215K Sell
237
-24
-9% -$19.2K 0.03% 60
2024
Q1
$203K Buy
+261
New +$186K 0.03% 70

Other funds holding LLY

Total Investment Management's LLY Position: Q2 2026 in Review

Total Investment Management increased its Eli Lilly (LLY) stake by 4.5% in Q2 2026, buying an estimated $11.2K and bringing the position to 256 shares worth $294K. The position accounts for 0.03% of the portfolio, ranked #62.

Total Investment Management first reported a position in LLY in Q1 2024 and has held it in 8 quarters since. 4,598 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Total Investment Management held 256 shares of Eli Lilly worth $294K as of Q2 2026.
  • Total Investment Management bought 11 Eli Lilly shares in Q2 2026, an estimated $11.2K.
  • Eli Lilly made up 0.03% of Total Investment Management's portfolio in Q2 2026, its #62 holding.
  • Total Investment Management first reported a position in Eli Lilly in Q1 2024 and has held it in 8 quarters since.
  • 4,598 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Total Investment Management's 13F filing for Q2 2026, filed 3 Aug 2026.